Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HeartRhythm case reports 2022-03, Vol.8 (3), p.191-194
Hauptverfasser: Tejeda-Mollinedo, Williams, Díaz-Tostado, Sergio, Gómez-Flores, Jorge, Nava-Townsend, Santiago, Levinstein-Jacinto, Moises, Márquez, Manlio F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 194
container_issue 3
container_start_page 191
container_title HeartRhythm case reports
container_volume 8
creator Tejeda-Mollinedo, Williams
Díaz-Tostado, Sergio
Gómez-Flores, Jorge
Nava-Townsend, Santiago
Levinstein-Jacinto, Moises
Márquez, Manlio F.
description
doi_str_mv 10.1016/j.hrcr.2021.12.006
format Article
fullrecord <record><control><sourceid>elsevier_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9039562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2214027121002402</els_id><sourcerecordid>S2214027121002402</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2886-a70c1fe0d2ea7b5b6fdd09fd3aee7f8b15466acadd5333a7b2ab13744d8c85b83</originalsourceid><addsrcrecordid>eNp9kd9qFDEUh4MottS-gBdyLvVixiTzH0QopVWhIEK9DpnkzG622WQ4mdbuk_gefRCfySyrpd54lQPn9_tC8jH2WvBScNG-35RrMlRKLkUpZMl5-4wdSynqgstOPH8yH7HTlDacc1EPsqqHl-yoavLY1_0x-3lxb9B7DAsQpjmGhLBE-PVQCNCWMCCtnMk7g_MSCUYfzY22CG-3uMSZoo_-HehgAe-RjMv1zFnImcXFAC7A2q3WBbl0A8tuRhDgY1jBt2tIu2ApbrGEM5Cy2KEmmKL38UdxO79iLybtE57-OU_Y98uL6_PPxdXXT1_Oz64KI_u-LXTHjZiQW4m6G5uxnazlw2QrjdhN_Siaum210dY2VVXliNSjqLq6tr3pm7GvTtjHA3e-HbdoTf4I0l7N5Laadipqp_7dBLdWq3inBl4NTSszQB4AhmJKhNNjV3C1N6U2am9K7U0pIVU2lUtvnt76WPnrJQc-HAKY337nkFQyDoNB67KKRdno_sf_DYtIqYA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Tejeda-Mollinedo, Williams ; Díaz-Tostado, Sergio ; Gómez-Flores, Jorge ; Nava-Townsend, Santiago ; Levinstein-Jacinto, Moises ; Márquez, Manlio F.</creator><creatorcontrib>Tejeda-Mollinedo, Williams ; Díaz-Tostado, Sergio ; Gómez-Flores, Jorge ; Nava-Townsend, Santiago ; Levinstein-Jacinto, Moises ; Márquez, Manlio F.</creatorcontrib><identifier>ISSN: 2214-0271</identifier><identifier>EISSN: 2214-0271</identifier><identifier>DOI: 10.1016/j.hrcr.2021.12.006</identifier><identifier>PMID: 35492848</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Beta-blockers ; Case Report ; Long QT syndrome ; Metoprolol ; QT interval ; Sudden cardiac death ; Syncope</subject><ispartof>HeartRhythm case reports, 2022-03, Vol.8 (3), p.191-194</ispartof><rights>2021 Heart Rhythm Society</rights><rights>2021 Heart Rhythm Society. Published by Elsevier Inc. 2021 Heart Rhythm Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2886-a70c1fe0d2ea7b5b6fdd09fd3aee7f8b15466acadd5333a7b2ab13744d8c85b83</cites><orcidid>0000-0003-3160-1266</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039562/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039562/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35492848$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tejeda-Mollinedo, Williams</creatorcontrib><creatorcontrib>Díaz-Tostado, Sergio</creatorcontrib><creatorcontrib>Gómez-Flores, Jorge</creatorcontrib><creatorcontrib>Nava-Townsend, Santiago</creatorcontrib><creatorcontrib>Levinstein-Jacinto, Moises</creatorcontrib><creatorcontrib>Márquez, Manlio F.</creatorcontrib><title>Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up</title><title>HeartRhythm case reports</title><addtitle>HeartRhythm Case Rep</addtitle><subject>Beta-blockers</subject><subject>Case Report</subject><subject>Long QT syndrome</subject><subject>Metoprolol</subject><subject>QT interval</subject><subject>Sudden cardiac death</subject><subject>Syncope</subject><issn>2214-0271</issn><issn>2214-0271</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kd9qFDEUh4MottS-gBdyLvVixiTzH0QopVWhIEK9DpnkzG622WQ4mdbuk_gefRCfySyrpd54lQPn9_tC8jH2WvBScNG-35RrMlRKLkUpZMl5-4wdSynqgstOPH8yH7HTlDacc1EPsqqHl-yoavLY1_0x-3lxb9B7DAsQpjmGhLBE-PVQCNCWMCCtnMk7g_MSCUYfzY22CG-3uMSZoo_-HehgAe-RjMv1zFnImcXFAC7A2q3WBbl0A8tuRhDgY1jBt2tIu2ApbrGEM5Cy2KEmmKL38UdxO79iLybtE57-OU_Y98uL6_PPxdXXT1_Oz64KI_u-LXTHjZiQW4m6G5uxnazlw2QrjdhN_Siaum210dY2VVXliNSjqLq6tr3pm7GvTtjHA3e-HbdoTf4I0l7N5Laadipqp_7dBLdWq3inBl4NTSszQB4AhmJKhNNjV3C1N6U2am9K7U0pIVU2lUtvnt76WPnrJQc-HAKY337nkFQyDoNB67KKRdno_sf_DYtIqYA</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Tejeda-Mollinedo, Williams</creator><creator>Díaz-Tostado, Sergio</creator><creator>Gómez-Flores, Jorge</creator><creator>Nava-Townsend, Santiago</creator><creator>Levinstein-Jacinto, Moises</creator><creator>Márquez, Manlio F.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3160-1266</orcidid></search><sort><creationdate>20220301</creationdate><title>Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up</title><author>Tejeda-Mollinedo, Williams ; Díaz-Tostado, Sergio ; Gómez-Flores, Jorge ; Nava-Townsend, Santiago ; Levinstein-Jacinto, Moises ; Márquez, Manlio F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2886-a70c1fe0d2ea7b5b6fdd09fd3aee7f8b15466acadd5333a7b2ab13744d8c85b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Beta-blockers</topic><topic>Case Report</topic><topic>Long QT syndrome</topic><topic>Metoprolol</topic><topic>QT interval</topic><topic>Sudden cardiac death</topic><topic>Syncope</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tejeda-Mollinedo, Williams</creatorcontrib><creatorcontrib>Díaz-Tostado, Sergio</creatorcontrib><creatorcontrib>Gómez-Flores, Jorge</creatorcontrib><creatorcontrib>Nava-Townsend, Santiago</creatorcontrib><creatorcontrib>Levinstein-Jacinto, Moises</creatorcontrib><creatorcontrib>Márquez, Manlio F.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>HeartRhythm case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tejeda-Mollinedo, Williams</au><au>Díaz-Tostado, Sergio</au><au>Gómez-Flores, Jorge</au><au>Nava-Townsend, Santiago</au><au>Levinstein-Jacinto, Moises</au><au>Márquez, Manlio F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up</atitle><jtitle>HeartRhythm case reports</jtitle><addtitle>HeartRhythm Case Rep</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>8</volume><issue>3</issue><spage>191</spage><epage>194</epage><pages>191-194</pages><issn>2214-0271</issn><eissn>2214-0271</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>35492848</pmid><doi>10.1016/j.hrcr.2021.12.006</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-3160-1266</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2214-0271
ispartof HeartRhythm case reports, 2022-03, Vol.8 (3), p.191-194
issn 2214-0271
2214-0271
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9039562
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Beta-blockers
Case Report
Long QT syndrome
Metoprolol
QT interval
Sudden cardiac death
Syncope
title Excellent response to β-1 adrenergic receptor blockade (metoprolol) and exercise restriction in high-risk type 1 long QT syndrome. A 22-year follow-up
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A33%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Excellent%20response%20to%20%CE%B2-1%20adrenergic%20receptor%20blockade%20(metoprolol)%20and%20exercise%20restriction%20in%20high-risk%20type%201%20long%20QT%20syndrome.%20A%2022-year%20follow-up&rft.jtitle=HeartRhythm%20case%20reports&rft.au=Tejeda-Mollinedo,%20Williams&rft.date=2022-03-01&rft.volume=8&rft.issue=3&rft.spage=191&rft.epage=194&rft.pages=191-194&rft.issn=2214-0271&rft.eissn=2214-0271&rft_id=info:doi/10.1016/j.hrcr.2021.12.006&rft_dat=%3Celsevier_pubme%3ES2214027121002402%3C/elsevier_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35492848&rft_els_id=S2214027121002402&rfr_iscdi=true